Repository of Research and Investigative Information

Repository of Research and Investigative Information

Baqiyatallah University of Medical Sciences

Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases

(2020) Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases. Current Pharmaceutical Biotechnology. pp. 1342-1353. ISSN 1389-2010

Full text not available from this repository.

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

An increase in the prevalence of Inflammatory Bowel Diseases (IBD) as a multifactorial intestinal chronic inflammation as well as the absence of a certain cure, has created an innovative era in the management of IBD by molecule/pathway-based anti-inflammatory approaches. There are credible documentations that demonstrate Mitogen-Activated Protein Kinases (MAPK) acts as IBD regulator. Upon the activation of MAPK signalling pathway, the transcription and expression of various encoding inflammatory molecules implicated in IBD are altered, thereby exacerbating the inflammation development. The current pharmacological management of IBD, including drug and biological therapies are expensive, possess temporary relief and some adverse effects. In this context, a variety of dietary fruits or medicinal herbs have received worldwide attention versus the development of IBD. Infact, natural ingredients, such as Flavaglines, Fisetin, Myricitrin, Cardamonin, Curcumin, Octacosanol and Mangiferin possess protective and therapeutic effects against IBD via modulation of different segments of MAPK signaling pathway. This review paper calls attention to the role of MAPK signaling triggered by natural products in the prevention and treatment of IBD.

Item Type: Article
Keywords: Natural product IBD MAPK natural dietary supplement ulcerative colitis therapeutic target nf-kappa-b randomized clinical-trial ameliorates experimental colitis sodium-induced colitis dss-induced colitis ulcerative-colitis map kinase p38 mapk double-blind maintaining remission Biochemistry & Molecular Biology Pharmacology & Pharmacy
Page Range: pp. 1342-1353
Journal or Publication Title: Current Pharmaceutical Biotechnology
Journal Index: ISI
Volume: 21
Number: 13
Identification Number: https://doi.org/10.2174/1389201021666191216122555
ISSN: 1389-2010
Depositing User: مهندس مهدی شریفی
URI: http://eprints.bmsu.ac.ir/id/eprint/8989

Actions (login required)

View Item View Item